{"id":44861,"date":"2022-11-01T00:04:34","date_gmt":"2022-11-01T04:04:34","guid":{"rendered":"https:\/\/reviewofmm.com\/?p=44861"},"modified":"2022-10-31T09:53:49","modified_gmt":"2022-10-31T13:53:49","slug":"vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results","status":"publish","type":"post","link":"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/","title":{"rendered":"Vyluma&#8217;s Navneet Puri and Raul Trillo Discuss CHAMP Study Results"},"content":{"rendered":"<p>sponsored content<\/p>\n<p><strong>November 1, 2022<\/strong><\/p>\n<p><iframe loading=\"lazy\" src=\"https:\/\/player.vimeo.com\/video\/764969002?h=205a498d61&amp;title=0&amp;byline=0&amp;portrait=0\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p><em>Review of Myopia Management&#8217;s<\/em> Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, interviewed Vyluma executives Navneet Puri, PhD, Founder, Chairman, and Chief Executive Officer, and Raul Trillo, MD, MBA, Chief Commercial Officer at the American Academy of Optometry&#8217;s Annual Meeting in San Diego to learn more about the results from the company&#8217;s three-year CHAMP (Childhood Atropine for Myopia Progression) Study.<\/p>\n<p>Building off the company&#8217;s presentation of the results from CHAMP, Dr. Puri and Dr. Trillo shared more insights on the design of the clinical trial, Vyluma&#8217;s interest in developing the NVK002 formula, and what the future holds for the study and gaining regulatory approval for the product.<\/p>\n<p>To learn more about Vyluma&#8217;s CHAMP Study, <strong><a href=\"https:\/\/reviewofmm.com\/vyluma-champ-pivotal-phase-3-clinical-trial-qa\/\" target=\"_blank\" rel=\"noopener\">read this Q&amp;A<\/a><\/strong> with Dr. Puri, Dr. Trillo, and Karla Zadnik, OD, PhD, Principal Investigator.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>sponsored content November 1, 2022 Review of Myopia Management&#8217;s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, interviewed Vyluma executives Navneet Puri, PhD, Founder, Chairman, and Chief Executive Officer, and Raul Trillo, MD, MBA, Chief Commercial Officer at the American Academy of Optometry&#8217;s Annual Meeting in San Diego to learn more about the results from the company&#8217;s three-year CHAMP (Childhood Atropine for Myopia Progression) Study. Building off the company&#8217;s presentation of the results from CHAMP, Dr. Puri and Dr. Trillo shared more insights on the design of the clinical trial, Vyluma&#8217;s interest in developing the NVK002 formula, and what the future holds for the study and gaining regulatory approval for the product. To learn more about Vyluma&#8217;s CHAMP Study, read this Q&amp;A with Dr. Puri, Dr. Trillo, and Karla Zadnik, OD, PhD, Principal Investigator.<\/p>\n","protected":false},"author":375,"featured_media":44862,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1355,1545,1636,1504,1620,2246,1610],"tags":[1611,1106,3861,1538,3834,452,698,1067,1584,2343,2664,2963,2346,1983,2767,3220,1731,284,2912,2663],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Vyluma&#039;s Navneet Puri and Raul Trillo Discuss CHAMP Study Results - Review of Myopia Management<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vyluma&#039;s Navneet Puri and Raul Trillo Discuss CHAMP Study Results - Review of Myopia Management\" \/>\n<meta property=\"og:description\" content=\"sponsored content November 1, 2022 Review of Myopia Management&#8217;s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, interviewed Vyluma executives Navneet Puri, PhD, Founder, Chairman, and Chief Executive Officer, and Raul Trillo, MD, MBA, Chief Commercial Officer at the American Academy of Optometry&#8217;s Annual Meeting in San Diego to learn more about the results from the company&#8217;s three-year CHAMP (Childhood Atropine for Myopia Progression) Study. Building off the company&#8217;s presentation of the results from CHAMP, Dr. Puri and Dr. Trillo shared more insights on the design of the clinical trial, Vyluma&#8217;s interest in developing the NVK002 formula, and what the future holds for the study and gaining regulatory approval for the product. To learn more about Vyluma&#8217;s CHAMP Study, read this Q&amp;A with Dr. Puri, Dr. Trillo, and Karla Zadnik, OD, PhD, Principal Investigator.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Review of Myopia Management\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-01T04:04:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-10-31T13:53:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/reviewofmm.com\/wp-content\/uploads\/2022\/10\/Vyluma-Video.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"898\" \/>\n\t<meta property=\"og:image:height\" content=\"441\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kristen Dalli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kristen Dalli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/\",\"url\":\"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/\",\"name\":\"Vyluma's Navneet Puri and Raul Trillo Discuss CHAMP Study Results - Review of Myopia Management\",\"isPartOf\":{\"@id\":\"https:\/\/reviewofmm.com\/#website\"},\"datePublished\":\"2022-11-01T04:04:34+00:00\",\"dateModified\":\"2022-10-31T13:53:49+00:00\",\"author\":{\"@id\":\"https:\/\/reviewofmm.com\/#\/schema\/person\/f943d3b48eea27bd0425746fe057dac7\"},\"breadcrumb\":{\"@id\":\"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/reviewofmm.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vyluma&#8217;s Navneet Puri and Raul Trillo Discuss CHAMP Study Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/reviewofmm.com\/#website\",\"url\":\"https:\/\/reviewofmm.com\/\",\"name\":\"Review of Myopia Management\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/reviewofmm.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/reviewofmm.com\/#\/schema\/person\/f943d3b48eea27bd0425746fe057dac7\",\"name\":\"Kristen Dalli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/reviewofmm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9d10679bcf35e426531ce6d2b8d0b60e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9d10679bcf35e426531ce6d2b8d0b60e?s=96&d=mm&r=g\",\"caption\":\"Kristen Dalli\"},\"url\":\"https:\/\/reviewofmm.com\/author\/kdalli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vyluma's Navneet Puri and Raul Trillo Discuss CHAMP Study Results - Review of Myopia Management","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/","og_locale":"en_US","og_type":"article","og_title":"Vyluma's Navneet Puri and Raul Trillo Discuss CHAMP Study Results - Review of Myopia Management","og_description":"sponsored content November 1, 2022 Review of Myopia Management&#8217;s Chief Medical Editor Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE, interviewed Vyluma executives Navneet Puri, PhD, Founder, Chairman, and Chief Executive Officer, and Raul Trillo, MD, MBA, Chief Commercial Officer at the American Academy of Optometry&#8217;s Annual Meeting in San Diego to learn more about the results from the company&#8217;s three-year CHAMP (Childhood Atropine for Myopia Progression) Study. Building off the company&#8217;s presentation of the results from CHAMP, Dr. Puri and Dr. Trillo shared more insights on the design of the clinical trial, Vyluma&#8217;s interest in developing the NVK002 formula, and what the future holds for the study and gaining regulatory approval for the product. To learn more about Vyluma&#8217;s CHAMP Study, read this Q&amp;A with Dr. Puri, Dr. Trillo, and Karla Zadnik, OD, PhD, Principal Investigator.","og_url":"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/","og_site_name":"Review of Myopia Management","article_published_time":"2022-11-01T04:04:34+00:00","article_modified_time":"2022-10-31T13:53:49+00:00","og_image":[{"width":898,"height":441,"url":"https:\/\/reviewofmm.com\/wp-content\/uploads\/2022\/10\/Vyluma-Video.jpg","type":"image\/jpeg"}],"author":"Kristen Dalli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Kristen Dalli","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/","url":"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/","name":"Vyluma's Navneet Puri and Raul Trillo Discuss CHAMP Study Results - Review of Myopia Management","isPartOf":{"@id":"https:\/\/reviewofmm.com\/#website"},"datePublished":"2022-11-01T04:04:34+00:00","dateModified":"2022-10-31T13:53:49+00:00","author":{"@id":"https:\/\/reviewofmm.com\/#\/schema\/person\/f943d3b48eea27bd0425746fe057dac7"},"breadcrumb":{"@id":"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/reviewofmm.com\/"},{"@type":"ListItem","position":2,"name":"Vyluma&#8217;s Navneet Puri and Raul Trillo Discuss CHAMP Study Results"}]},{"@type":"WebSite","@id":"https:\/\/reviewofmm.com\/#website","url":"https:\/\/reviewofmm.com\/","name":"Review of Myopia Management","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reviewofmm.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/reviewofmm.com\/#\/schema\/person\/f943d3b48eea27bd0425746fe057dac7","name":"Kristen Dalli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/reviewofmm.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9d10679bcf35e426531ce6d2b8d0b60e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9d10679bcf35e426531ce6d2b8d0b60e?s=96&d=mm&r=g","caption":"Kristen Dalli"},"url":"https:\/\/reviewofmm.com\/author\/kdalli\/"}]}},"parsely":{"version":"1.1.0","meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Vyluma&#8217;s Navneet Puri and Raul Trillo Discuss CHAMP Study Results","url":"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/reviewofmm.com\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\/"},"thumbnailUrl":"https:\/\/reviewofmm.com\/wp-content\/uploads\/2022\/10\/Vyluma-Video-150x74.jpg","image":{"@type":"ImageObject","url":"https:\/\/reviewofmm.com\/wp-content\/uploads\/2022\/10\/Vyluma-Video.jpg"},"articleSection":"Multimedia","author":[{"@type":"Person","name":"Kristen Dalli"}],"creator":["Kristen Dalli"],"publisher":{"@type":"Organization","name":"Review of Myopia Management","logo":""},"keywords":["clinical","dwight akerman","karla zadnik","low-dose atropine","multimedia","myopia","myopia control","myopia management","myopia progression","navneet puri","nvk002","pharmaceutical interventions","products &amp; services","raul trillo","resources &amp; multimedia","sp:vyluma","sponsored content","videos","videos and podcasts","vyluma"],"dateCreated":"2022-11-01T04:04:34Z","datePublished":"2022-11-01T04:04:34Z","dateModified":"2022-11-01T04:04:34Z"},"rendered":"<script type=\"application\/ld+json\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Vyluma&#8217;s Navneet Puri and Raul Trillo Discuss CHAMP Study Results\",\"url\":\"https:\\\/\\\/reviewofmm.com\\\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\\\/\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/reviewofmm.com\\\/vylumas-navneet-puri-and-raul-trillo-discuss-champ-study-results\\\/\"},\"thumbnailUrl\":\"https:\\\/\\\/reviewofmm.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Vyluma-Video-150x74.jpg\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/reviewofmm.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Vyluma-Video.jpg\"},\"articleSection\":\"Multimedia\",\"author\":[{\"@type\":\"Person\",\"name\":\"Kristen Dalli\"}],\"creator\":[\"Kristen Dalli\"],\"publisher\":{\"@type\":\"Organization\",\"name\":\"Review of Myopia Management\",\"logo\":\"\"},\"keywords\":[\"clinical\",\"dwight akerman\",\"karla zadnik\",\"low-dose atropine\",\"multimedia\",\"myopia\",\"myopia control\",\"myopia management\",\"myopia progression\",\"navneet puri\",\"nvk002\",\"pharmaceutical interventions\",\"products &amp; services\",\"raul trillo\",\"resources &amp; multimedia\",\"sp:vyluma\",\"sponsored content\",\"videos\",\"videos and podcasts\",\"vyluma\"],\"dateCreated\":\"2022-11-01T04:04:34Z\",\"datePublished\":\"2022-11-01T04:04:34Z\",\"dateModified\":\"2022-11-01T04:04:34Z\"}<\/script>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/reviewofmm.com\/p.js"},"cc_featured_image_caption":{"caption_text":"","source_text":"","source_url":""},"_links":{"self":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts\/44861"}],"collection":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/users\/375"}],"replies":[{"embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/comments?post=44861"}],"version-history":[{"count":3,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts\/44861\/revisions"}],"predecessor-version":[{"id":44865,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/posts\/44861\/revisions\/44865"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/media\/44862"}],"wp:attachment":[{"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/media?parent=44861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/categories?post=44861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/reviewofmm.com\/wp-json\/wp\/v2\/tags?post=44861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}